Arthritis Clinical Trials

Find Arthritis Clinical Trials Near You

Medium-and Long-term Efficacy of Two Ultrasound-guided Intra-articular Injections of onabotulinumtoxinA (Botox®) Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis : a Randomized Double-blind Controlled Trial in Three-parallel Arms

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY

The main objective of this study will be to compare the effects of 2 intra-articular injections of onabotulinumtoxinA with those of 1 intra-articular injection of onabotulinumtoxinA and 1 of normal saline and those of 2 intra-articular injections of normal saline on base-of-thumb pain at 6 months after the first injection.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• • Individuals aged at least 18 years;

‣ Pain intensity of at least 30 on a self-administered 11-point pain numeric rating scale (0: no pain to 100: maximal pain);

⁃ Pain involving the base of the thumb;

⁃ X-ray evidence of trapezometacarpial osteoarthritis with at least two of the following items involving the trapezometacarpial joint: osteophytes, joint space narrowing, subchondral bone sclerosis, or subchondral cysts;

⁃ 1990 ACR classification criteria for hand osteoarthritis adapted to trapezometacarpial osteoarthritis.

⁃ Patient able to give written informed consent prior to participation in the study

⁃ Affiliation with a mode of social security (profit or being entitled).

⁃ Negative pregnancy test in women of childbearing potential

Locations
Other Locations
France
Assistance Publique - Hôpitaux de Paris, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis du Pr François Rannou, Hôpital Cochin
RECRUITING
Paris
Contact Information
Primary
Christelle NGUYEN, MD, PhD
christelle.nguyen2@aphp.fr
01 58 41 29 45
Backup
Laetitia PEAUDECERF, PhD
laetitia.peaudecerf@aphp.fr
01 58 41 12 13
Time Frame
Start Date: 2025-12-03
Estimated Completion Date: 2028-11
Participants
Target number of participants: 120
Treatments
Experimental: 2 intra-articular injections of onabotulinumtoxinA
Experimental: 1 intra-articular injection of onabotulinumtoxinA and 1 of normal saline
Placebo_comparator: 2 intra-articular injections of normal saline
Related Therapeutic Areas
Sponsors
Collaborators: URC-CIC Paris Descartes Necker Cochin
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov

Similar Clinical Trials